<?xml version="1.0"?>
<bill bill-stage="Received-in-Senate" bill-type="olc" dms-id="H38E0FFC7AF764F39B0EB5DC1414744E5" public-private="public">
	<form>
		<distribution-code display="yes">II</distribution-code>
		<congress display="yes">110th CONGRESS</congress>
		<session display="yes">2d Session</session>
		<legis-num>H. R. 1157</legis-num>
		<current-chamber display="yes">IN THE SENATE OF THE UNITED
		  STATES</current-chamber>
		<action>
			<action-date date="20080926" legis-day="20080917">September 26
			 (legislative day, September 17), 2008</action-date>
			<action-desc>Received</action-desc>
		</action>
		<legis-type>AN ACT</legis-type>
		<official-title display="yes">To amend the Public Health Service Act to
		  authorize the Director of the National Institute of Environmental Health
		  Sciences to make grants for the development and operation of research centers
		  regarding environmental factors that may be related to the etiology of breast
		  cancer.</official-title>
	</form>
	<legis-body display-enacting-clause="yes-display-enacting-clause" id="H1A1430DC33CB40A580217300366F32A8" style="OLC">
		<section id="HC6D58AD25DEB4CFC9D703865ADEB017E" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the
			 <quote><short-title>Breast Cancer and Environmental
			 Research Act of 2008</short-title></quote>.</text>
		</section><section id="H2A767B3F415D409DB28E5EC859EC62BD"><enum>2.</enum><header>Expanding
			 collaborative research on breast cancer and the environment</header>
			<subsection id="HAA0929CE81E54D909D896E1C8BAEEEDE"><enum>(a)</enum><header>In
			 general</header><text display-inline="yes-display-inline">Subpart 1 of part C
			 of title IV of the Public Health Service Act (42 U.S.C. 285 et seq.) is amended
			 by adding at the end the following:</text>
				<quoted-block id="HFFB6AE27FF594EB38D9DDFDE2F932B05" style="OLC">
					<section id="H8FB107AB5DFE4E6DB7D870ADFECCE42E"><enum>417F.</enum><header>Interagency
				Breast Cancer and Environmental Research Coordinating Committee</header>
						<subsection id="H3EA86CB48A724DD284231D95451C67A8"><enum>(a)</enum><header>Interagency
				Breast Cancer and Environmental Research Coordinating Committee</header>
							<paragraph id="HDE011F33F5F64918A8E0AC7C58E34F84"><enum>(1)</enum><header>Establishment</header><text display-inline="yes-display-inline">Not later than 6 months after the date of
				the enactment of this section, the Secretary shall establish a committee, to be
				known as the Interagency Breast Cancer and Environmental Research Coordinating
				Committee (in this section referred to as the ‘Committee’).</text>
							</paragraph><paragraph id="H94C6B42392C9467685DEFFE46F20B720"><enum>(2)</enum><header>Duties</header><text>The
				Committee shall—</text>
								<subparagraph id="H434C827CB73E4C22BAC65E2797B82D23"><enum>(A)</enum><text display-inline="yes-display-inline">share and coordinate information on
				existing research activities, and make recommendations to the National
				Institutes of Health and other Federal agencies regarding how to improve
				existing research programs, that are related to breast cancer research;</text>
								</subparagraph><subparagraph id="H81330642E4044A7ABC37356B45E888C7"><enum>(B)</enum><text>develop a
				comprehensive strategy and advise the National Institutes of Health and other
				Federal agencies in the solicitation of proposals for collaborative,
				multidisciplinary research, including proposals to evaluate environmental and
				genomic factors that may be related to the etiology of breast cancer that
				would—</text>
									<clause id="H4C05EEF0C9634286BC48A95941E92B61"><enum>(i)</enum><text>result in
				innovative approaches to study emerging scientific opportunities or eliminate
				knowledge gaps in research to improve the research portfolio;</text>
									</clause><clause id="HB0B190EAAFFD45B9A1D5C84BFFEA7094"><enum>(ii)</enum><text>outline key
				research questions, methodologies, and knowledge gaps;</text>
									</clause><clause id="H07945F8BD3D14FA6A0C07DC3C1D7C908"><enum>(iii)</enum><text>expand the
				number of research proposals that involve collaboration between 2 or more
				national research institutes or national centers, including proposals for
				Common Fund research described in section 402(b)(7) to improve the research
				portfolio; and</text>
									</clause><clause id="HD7FB5CC674904864B563A4643F262C6B"><enum>(iv)</enum><text>expand the number
				of collaborative, multidisciplinary, and multi-institutional research
				grants;</text>
									</clause></subparagraph><subparagraph id="HAE975E051BF1439EA8C160D19E26AF7E"><enum>(C)</enum><text>develop a summary
				of advances in breast cancer research supported or conducted by Federal
				agencies relevant to the diagnosis, prevention, and treatment of cancer and
				other diseases and disorders; and</text>
								</subparagraph><subparagraph id="H92791F25032E4587ABB1745360E875DD"><enum>(D)</enum><text>not later than 2
				years after the date of the establishment of the Committee, make
				recommendations to the Secretary—</text>
									<clause id="HED8EDC9FE72749FBB92EE9D417648108"><enum>(i)</enum><text>regarding any
				appropriate changes to research activities, including recommendations to
				improve the research portfolio of the National Institutes of Health to ensure
				that scientifically-based strategic planning is implemented in support of
				research priorities that impact breast cancer research activities;</text>
									</clause><clause id="H7E0E7ED87A4148F79D5DD8A74EF428E6"><enum>(ii)</enum><text>to ensure that
				the activities of the National Institutes of Health and other Federal agencies,
				including the Department of Defense, are free of unnecessary duplication of
				effort;</text>
									</clause><clause id="HBE8189A318CC49BEA9B1604C73B7AD20"><enum>(iii)</enum><text>regarding public
				participation in decisions relating to breast cancer research to increase the
				involvement of patient advocacy and community organizations representing a
				broad geographical area;</text>
									</clause><clause id="H7386B11066A64125A925A45D1423A317"><enum>(iv)</enum><text>on how best to
				disseminate information on breast cancer research progress; and</text>
									</clause><clause id="HECAD16F169C7481689A006435733A2F8"><enum>(v)</enum><text display-inline="yes-display-inline">on how to expand partnerships between
				public entities, including Federal agencies, and private entities to expand
				collaborative, cross-cutting research.</text>
									</clause></subparagraph></paragraph><paragraph commented="no" id="HC2B68E2974FF4DD893D01C8B24B392D"><enum>(3)</enum><header>Rule of
				construction</header><text display-inline="yes-display-inline">For the purposes
				of the Committee, when focusing on research to evaluate environmental and
				genomic factors that may be related to the etiology of breast cancer, nothing
				in this section shall be construed to restrict the Secretary from including
				other forms of cancer, as appropriate, when doing so may advance research in
				breast cancer or advance research in other forms of cancer.</text>
							</paragraph><paragraph id="HFAC5C842879B483D903DA7BBDA3CE3D"><enum>(4)</enum><header>Membership</header>
								<subparagraph id="H017B289867EB4743904E95C0FB16A704"><enum>(A)</enum><header>In
				general</header><text>The Committee shall be composed of the following voting
				members:</text>
									<clause id="H8E196A5A27BA4D3D9B75DC935B277250"><enum>(i)</enum><text>Not more than 7
				voting Federal representatives as follows:</text>
										<subclause id="H4087B5D479154D99A8128C1D03EC94C3"><enum>(I)</enum><text>The Director of
				the Centers for Disease Control and Prevention.</text>
										</subclause><subclause id="HC22529FBB7E44398A986A79CAAC0EF49"><enum>(II)</enum><text display-inline="yes-display-inline">The Director of the National Institutes of
				Health and the directors of such national research institutes and national
				centers (which may include the National Institute of Environmental Health
				Sciences) as the Secretary determines appropriate.</text>
										</subclause><subclause id="H54E9D918E979471C88494C40D1783DCD"><enum>(III)</enum><text>One
				representative from the National Cancer Institute Board of Scientific Advisors,
				appointed by the Director of the National Cancer Institute.</text>
										</subclause><subclause id="H8FD4C16592C3481599A02FDFE3CB982"><enum>(IV)</enum><text>The heads of such
				other agencies of the Department of Health and Human Services as the Secretary
				determines appropriate.</text>
										</subclause><subclause id="H77DD53E0A3154DB89E1F2D65C2DD133"><enum>(V)</enum><text>Representatives of
				other Federal agencies that conduct or support cancer research, including the
				Department of Defense.</text>
										</subclause></clause><clause id="HBD3E7FB90E234B4792F0FDE4A91C01FC"><enum>(ii)</enum><text>12 additional
				voting members appointed under subparagraph (B).</text>
									</clause></subparagraph><subparagraph id="HB9117C03DB1045378563B71FD24B1718"><enum>(B)</enum><header>Additional
				members</header><text>The Committee shall include additional voting members
				appointed by the Secretary as follows:</text>
									<clause id="HD1BE813CC38C476082F1BC4572889DA"><enum>(i)</enum><text>6
				members shall be appointed from among scientists, physicians, and other health
				professionals, who—</text>
										<subclause id="H794FA2608204490DA9FF95832100B512"><enum>(I)</enum><text>are not officers
				or employees of the United States;</text>
										</subclause><subclause id="H8B15DEB98B314AF4835161ED3E7E8580"><enum>(II)</enum><text>represent
				multiple disciplines, including clinical, basic, and public health
				sciences;</text>
										</subclause><subclause id="H09CCC33B49914D748BB0D30032693766"><enum>(III)</enum><text>represent
				different geographical regions of the United States;</text>
										</subclause><subclause id="HC90718E27D0B4C64B7FF7FE1A654F4C1"><enum>(IV)</enum><text>are from practice
				settings, academia, or other research settings; and</text>
										</subclause><subclause id="HDFEF4BC02FCB48C4832844C109033E93"><enum>(V)</enum><text>are experienced in
				scientific peer review process.</text>
										</subclause></clause><clause id="HD2DF9076F67A4A30B57C6C22089E2C2E"><enum>(ii)</enum><text display-inline="yes-display-inline">6 members shall be appointed from members
				of the general public, who represent individuals with breast cancer.</text>
									</clause></subparagraph><subparagraph id="H897BC3041AFE446EA62134ABE93FF53F"><enum>(C)</enum><header>Nonvoting
				members</header><text>The Committee shall include such nonvoting members as the
				Secretary determines to be appropriate.</text>
								</subparagraph></paragraph><paragraph id="HCE644709AE474CBE98736C6B89A7F11C"><enum>(5)</enum><header>Chairperson</header><text>The
				voting members of the Committee shall select a chairperson from among such
				members. The selection of a chairperson shall be subject to the approval of the
				Director of NIH.</text>
							</paragraph><paragraph id="HD5F68AA126F44C2AAA00962C0059A8DB"><enum>(6)</enum><header>Meetings</header><text>The
				Committee shall meet at the call of the chairperson of the Committee or upon
				the request of the Director of NIH, but in no case less often than once each
				year.</text>
							</paragraph></subsection><subsection commented="no" id="H4747F99FFE334790B83ED96700D413DE"><enum>(b)</enum><header>Review</header><text display-inline="yes-display-inline">The Secretary shall review the necessity of
				the Committee in calendar year 2011 and, thereafter, at least once every 2
				years.</text>
						</subsection></section><after-quoted-block>.</after-quoted-block></quoted-block>
			</subsection><subsection id="HA03113189C694F56865588D9F6F825A6"><enum>(b)</enum><header>Authorization of
			 appropriations</header><text>For the purpose of carrying out research
			 activities under title IV of the Public Health Service Act, including section
			 417F of such Act as added by subsection (a), there are authorized to be
			 appropriated $40,000,000 for each of fiscal years 2009 through 2012. Amounts
			 authorized to be appropriated under the preceding sentence shall be in addition
			 to amounts otherwise authorized to be appropriated for such purpose under
			 section 402A of the Public Health Service Act (42 U.S.C. 282a).</text>
			</subsection></section></legis-body>
	<attestation>
		<attestation-group>
			<attestation-date chamber="House" date="20080925">Passed the House of
			 Representatives September 25, 2008.</attestation-date>
			<attestor display="yes">Lorraine C. Miller,</attestor>
			<role>Clerk.</role>
		</attestation-group>
	</attestation>
</bill>
